These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9436731)

  • 21. Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study.
    Korinthenberg R; Mönting JS
    Arch Dis Child; 1996 Apr; 74(4):281-7. PubMed ID: 8669925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoglobulins in the treatment of Guillain-Barré syndrome in early childhood.
    al-Qudah AA
    J Child Neurol; 1994 Apr; 9(2):178-80. PubMed ID: 8006371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.
    van der Meché FG; Schmitz PI
    N Engl J Med; 1992 Apr; 326(17):1123-9. PubMed ID: 1552913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome.
    Ann Neurol; 1997 Mar; 41(3):298-306. PubMed ID: 9066350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Guillain-Barré Syndrome Steroid Trial Group.
    Lancet; 1993 Mar; 341(8845):586-90. PubMed ID: 8094828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Raphaël JC; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2001; (2):CD002063. PubMed ID: 11406030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Guillain-Barre syndrome and pregnancy].
    Bouaggad A; Bouderka MA; Laraki M; Barrou H; Harti A; Benaguida M
    Rev Fr Gynecol Obstet; 1994 Feb; 89(2):86-7. PubMed ID: 8184251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guillain-Barré syndrome in children.
    Jones HR
    Curr Opin Pediatr; 1995 Dec; 7(6):663-8. PubMed ID: 8776016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management and outcome of severe Guillain-Barré syndrome.
    Ng KK; Howard RS; Fish DR; Hirsch NP; Wiles CM; Murray NM; Miller DH
    QJM; 1995 Apr; 88(4):243-50. PubMed ID: 7796073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An epidemiologic, clinical, and therapeutic study of childhood Guillain-Barré syndrome in Kuwait: is it related to the oral polio vaccine?
    Ismail EA; Shabani IS; Badawi M; Sanaa H; Madi S; Al-Tawari A; Nadi H; Zaki M; Al-saleh Q
    J Child Neurol; 1998 Oct; 13(10):488-92. PubMed ID: 9796754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Raphaël JC; Swan AV; Doorn PA
    Cochrane Database Syst Rev; 2004; (1):CD002063. PubMed ID: 14973982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma exchange treatment and prognosis of Guillain-Barré syndrome.
    Smith GD; Hughes RA
    Q J Med; 1992 Oct; 85(306):751-60. PubMed ID: 1287706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.
    Lasky T; Terracciano GJ; Magder L; Koski CL; Ballesteros M; Nash D; Clark S; Haber P; Stolley PD; Schonberger LB; Chen RT
    N Engl J Med; 1998 Dec; 339(25):1797-802. PubMed ID: 9854114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis in severe Guillain-Barré syndrome.
    Cole GF; Matthew DJ
    Arch Dis Child; 1987 Mar; 62(3):288-91. PubMed ID: 3566320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiologic study of Guillain-Barré syndrome in children <15 years of age in Latin America.
    Olivé JM; Castillo C; Castro RG; de Quadros CA
    J Infect Dis; 1997 Feb; 175 Suppl 1():S160-4. PubMed ID: 9203710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Guillain-Barré syndrome. A review of admissions to an intensive care unit over 8 years.
    Beale EO; Miller MT
    S Afr Med J; 1985 Jan; 67(1):10-2. PubMed ID: 3966177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Campylobacter 0:41 isolation in Guillain-Barré syndrome.
    Goddard EA; Lastovica AJ; Argent AC
    Arch Dis Child; 1997 Jun; 76(6):526-8. PubMed ID: 9245852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of Guillain-Barré syndrome mortality and morbidity in the United States: implications for acute flaccid paralysis surveillance.
    Prevots DR; Sutter RW
    J Infect Dis; 1997 Feb; 175 Suppl 1():S151-5. PubMed ID: 9203708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma exchange for Guillain-Barré syndrome.
    Raphaël JC; Chevret S; Hughes RA; Annane D
    Cochrane Database Syst Rev; 2001; (2):CD001798. PubMed ID: 11406009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased incidence of Guillain-Barré syndrome postpartum.
    Cheng Q; Jiang GX; Fredrikson S; Link H; de Pedro-Cuesta J
    Epidemiology; 1998 Nov; 9(6):601-4. PubMed ID: 9799167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.